Ethics for CHIM Clinical Trial Protocols Workshop

Ethics for CHIM Clinical Trial Protocols Workshop

Brussels, Belgium

May 30-31, 2023

On invitation only

Scientific Agenda

For further information contact the secretariat

Maintaining the Quality of Vaccines through the Use of References Standards Current Challenges and Future Opportunities

Ottawa, Canada
Hybrid meeting

June 21-22, 2023

Learn more & Register now

IABS – Flanders Vaccine 
The Role of Real-World Evidence for Regulatory and Public Health Decision Making for Accelerated Vaccine Deployment

Leuven, Belgium

September 19-20, 2023

Learn more & Register now

9th Annual Statistics Workshop
Statistical Innovation Advancing

Rockville, USA
November  7-9, 2023.
Learn more & Register



Register now

IABS is organizing the upcoming event about Maintaning the Quality of Vaccines Through the Use of References Standards : Current Challenges and Future Opportunities. The meeting will take place on 21 and 22 of June, 2023, at the Library…

Read more

President’s Column 2022

Dear IABS Colleagues, Stakeholders, Supporters, and Collaborators,
It was an honor to assume the presidency of this prestigious organization in 2022.  IABS has a celebrated history, and I am looking forward to more accomplishments…

Read more

What does IABS do that is unique ?

In this short interview, Joris Vandeputte, former President of IABS has answered the question “What does IABS do that is unique ?”
To learn more about the International Alliance for Biological…

Read more



IMI is a European public-private partnership aiming to speed up the development of better and safer medicines. IMI is partly founded by the European Commission.

The IABS European Affiliate (IABS-EU) was part of consortia which have  been selected by IMI to be the public partners of following consortia.

IABS-EU was selected to drive the regulatory part of those consortia.


MANCO (Monclonal Antibodies against COVID-19) is one of the eighteen projects that have been successfully selected by the European Commission, which is devoted to the development of Monoclonal Antibodies agains COVID-19.

IABES-EU was selected to drive the regulatory part of the project


Paul Henri Lambert

Professor at University of Geneva
Founder of ADVAC

 “I have appreciated the achievements of IABS since many years. It is a unique independent organization that can…

Read more

John Petricciani

Past President
Advisor to the Board

“ Cell substrates have been a key element in the evolution of biological products since the…

Read more

Kathryn Zoon

NIH Scientist Emeritus
Past NIAID Scientific Director

As a long term US regulator and scientist, I have been working with IABS for many years. The IABS has …

Read more

Philippe Duclos

Director ADVAC
University of Geneva

“ A vibrant organization that allows dialogue beyond professional boundaries…

Read more